Chronic Heart Failure Clinical Trial
Official title:
Fear of Activity in Situations (FActS) - Heart Failure Study 2016
NCT number | NCT02898246 |
Other study ID # | FActS Study 2016 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | November 2016 |
Est. completion date | July 2019 |
Verified date | September 2019 |
Source | University of Trier |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of the study is to evaluate the psychometric properties of the newly developed Fear of Activity in Situations - Heart Failure (FActS-HF 15) scale. The FActS-HF 15 is a questionnaire assessing fear of physical activity (fear of movement) in patients with chronic heart failure. FActS-HF 15 assesses cognitions and emotions that can occur during physical activity, independent of avoidance behavior. Firstly, the study aims at evaluating the instrument's reliability and validity and to investigate associations of fear of physical activity with demographic, medical, and psychosocial patient characteristics. Secondly, the study aims at assessing everyday physical activity using accelerometric measures to test the hypothesis that fear of physical activity in patients with heart failure is related with lower actual physical activity.
Status | Completed |
Enrollment | 187 |
Est. completion date | July 2019 |
Est. primary completion date | July 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Clinical diagnosis of heart failure stage B or C (Hunt et al., 2005), or: New York Heart Failure classification II to IIIb: 1. Systolic dysfunction: left ventricular ejection fraction < 45% in the last 6 month 2. Diastolic dysfunction: left ventricular ejection fraction >= 45% in the last 6 month Exclusion Criteria: - complex ventricular arrhythmias - acute myocarditis - symptomatic cardiac valve stenosis - instable angina pectoris - other severe diseases, that impair physical activity (e.g., advanced stages of cancer) - insufficient language skills in German to answer the questionnaires - insufficient cognitive skills to answer the questionnaires |
Country | Name | City | State |
---|---|---|---|
Germany | Universitätsklinikum Aachen | Aachen | |
Germany | Universitätsklinikum des Saarlands | Homburg | |
Germany | Geriatrische Rehabilitationsklinik St. Irminen | Trier | |
Germany | Krankenhaus der Barmherzigen Brüder Trier | Trier | |
Germany | Mutterhaus der Borromäerinnen | Trier | |
Germany | Rhein-Maas-Klinikum | Würselen |
Lead Sponsor | Collaborator |
---|---|
University of Trier | Geriatric Rehabilitation Clinic St. Irminen, Krankenhaus der Barmherzigen Brüder Trier, RWTH Aachen University, University Hospital, Saarland |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | FActS-HF 15 total score and subscores | The psychometric properties of FActS-HF 15 are assessed in terms of item analysis, reliability (internal consistency, test-retest reliability), convergent and discriminant validity (correlations with other questionnaires) as well as confirmatory factor analysis (assessing the dimensionality). Associations with demographic, medical, and psychosocial variables will be evaluated. | 2016-2019 | |
Secondary | Average daily energy expenditure due to physical activity (kcal/d) | Objectively assessed via accelerometry | 6 day assessment, after questionnaire completion | |
Secondary | Average intensity of physical activity (MET) | Objectively assessed via accelerometry | 6 day assessment, after questionnaire completion | |
Secondary | Average relative frequency of activity classes | Relative frequency of activity classes stair climbing, lying down, walking | 6 day assessment, after questionnaire completion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03597646 -
The Effect of Kinesio Taping on Pulmonary Function and Functional Capacity in Patients With Chronic Heart Failure
|
N/A | |
Terminated |
NCT04065997 -
Apogee International
|
||
Withdrawn |
NCT03675113 -
Effect of Upper Extremity Aerobic Exercise Training on Exercise Capacity Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02916160 -
Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study
|
Phase 4 | |
Completed |
NCT03126656 -
Effects of Testosterone on Myocardial Repolarization
|
Phase 4 | |
Completed |
NCT02247245 -
The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.
|
N/A | |
Completed |
NCT02268500 -
VAccination to Improve Clinical outComes in Heart Failure Trial: a Feasibility Study (VACC-HeFT)
|
Phase 4 | |
Terminated |
NCT01906957 -
Cognition and Exercise Training
|
N/A | |
Completed |
NCT01919918 -
Muscle Afferent Feedback Effects in Patients With Heart Failure
|
Phase 1 | |
Not yet recruiting |
NCT01669395 -
Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial
|
N/A | |
Completed |
NCT00984529 -
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
|
N/A | |
Recruiting |
NCT00863421 -
Sleep Disordered Breathing in Patients With Chronic Heart Failure
|
N/A | |
Completed |
NCT02840565 -
Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453
|
Phase 1 | |
Completed |
NCT02441218 -
Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study
|
Phase 3 | |
Completed |
NCT00149409 -
Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
|
Phase 2/Phase 3 | |
Terminated |
NCT05532046 -
A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)
|
Phase 1 | |
Recruiting |
NCT04984928 -
Readmission Risk of Patients With Heart Failure.
|
||
Completed |
NCT02814097 -
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Active, not recruiting |
NCT05560737 -
ODYSSEE-vCHAT Mental Health Program for Heart Failure and Kidney Disease Patients
|
||
Recruiting |
NCT03286127 -
Palliative Outcome Evaluation Muenster I
|